Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum

Detalhes bibliográficos
Autor(a) principal: Almeida, Ângela
Data de Publicação: 2022
Outros Autores: Calisto, Vânia, Esteves, Valdemar I., Schneider, Rudolf J., Soares, Amadeu M. V. M., Freitas, Rosa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/37737
Resumo: In coastal systems, pollutants as pharmaceutical drugs exert changes from the molecular to the organism level in marine bivalves. Besides pollutants, coastal systems are prone to changes in environmental parameters, as the alteration of salinity values because of Climate Change. Together, these stressors (pharmaceutical drugs and salinity changes) can exert different threats than each stressor acting individually; for example, salinity can change the physical-chemical properties of the drugs and/or the sensitivity of the organisms to them. However, limited information is available on this subject, with variable results, and for this reason, this study aimed to evaluate the impacts of salinity changes (15, 25 and 35) on the effects of the antiepileptic carbamazepine (CBZ, 1 μg/L) and the antihistamine cetirizine (CTZ, 0.6 μg/L), when acting individually and combined (CBZ + CTZ), in the edible clam Ruditapes philippinarum. After 28 days of exposure, drugs concentrations, bioconcentration factors and biochemical parameters, related to clam's metabolic capacity and oxidative stress were evaluated. The results showed that clams under low salinity suffered more changes in metabolic, antioxidant and biotransformation activities, in comparison with the remaining salinities under study. However, limited impacts were observed when comparing drug effects at low salinity. Indeed, it seemed that CTZ and CBZ + CTZ, under high salinity (salinity 35) were the worst exposure conditions for the clams, since they caused higher levels of cellular damage. It stands out that salinity changes altered the impact of pharmaceutical drugs on marine bivalves.
id RCAP_47ce409fb49f9a78795ec767607c3247
oai_identifier_str oai:ria.ua.pt:10773/37737
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarumPharmaceutical drugsBivalvesSalinityBiomarkersClimate changeIn coastal systems, pollutants as pharmaceutical drugs exert changes from the molecular to the organism level in marine bivalves. Besides pollutants, coastal systems are prone to changes in environmental parameters, as the alteration of salinity values because of Climate Change. Together, these stressors (pharmaceutical drugs and salinity changes) can exert different threats than each stressor acting individually; for example, salinity can change the physical-chemical properties of the drugs and/or the sensitivity of the organisms to them. However, limited information is available on this subject, with variable results, and for this reason, this study aimed to evaluate the impacts of salinity changes (15, 25 and 35) on the effects of the antiepileptic carbamazepine (CBZ, 1 μg/L) and the antihistamine cetirizine (CTZ, 0.6 μg/L), when acting individually and combined (CBZ + CTZ), in the edible clam Ruditapes philippinarum. After 28 days of exposure, drugs concentrations, bioconcentration factors and biochemical parameters, related to clam's metabolic capacity and oxidative stress were evaluated. The results showed that clams under low salinity suffered more changes in metabolic, antioxidant and biotransformation activities, in comparison with the remaining salinities under study. However, limited impacts were observed when comparing drug effects at low salinity. Indeed, it seemed that CTZ and CBZ + CTZ, under high salinity (salinity 35) were the worst exposure conditions for the clams, since they caused higher levels of cellular damage. It stands out that salinity changes altered the impact of pharmaceutical drugs on marine bivalves.Elsevier2024-02-01T00:00:00Z2022-02-01T00:00:00Z2022-02-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10773/37737eng0048-969710.1016/j.scitotenv.2021.150369Almeida, ÂngelaCalisto, VâniaEsteves, Valdemar I.Schneider, Rudolf J.Soares, Amadeu M. V. M.Freitas, Rosainfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-17T04:20:13ZPortal AgregadorONG
dc.title.none.fl_str_mv Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
title Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
spellingShingle Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
Almeida, Ângela
Pharmaceutical drugs
Bivalves
Salinity
Biomarkers
Climate change
title_short Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
title_full Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
title_fullStr Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
title_full_unstemmed Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
title_sort Salinity-dependent impacts on the effects of antiepileptic and antihistaminic drugs in Ruditapes philippinarum
author Almeida, Ângela
author_facet Almeida, Ângela
Calisto, Vânia
Esteves, Valdemar I.
Schneider, Rudolf J.
Soares, Amadeu M. V. M.
Freitas, Rosa
author_role author
author2 Calisto, Vânia
Esteves, Valdemar I.
Schneider, Rudolf J.
Soares, Amadeu M. V. M.
Freitas, Rosa
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Almeida, Ângela
Calisto, Vânia
Esteves, Valdemar I.
Schneider, Rudolf J.
Soares, Amadeu M. V. M.
Freitas, Rosa
dc.subject.por.fl_str_mv Pharmaceutical drugs
Bivalves
Salinity
Biomarkers
Climate change
topic Pharmaceutical drugs
Bivalves
Salinity
Biomarkers
Climate change
description In coastal systems, pollutants as pharmaceutical drugs exert changes from the molecular to the organism level in marine bivalves. Besides pollutants, coastal systems are prone to changes in environmental parameters, as the alteration of salinity values because of Climate Change. Together, these stressors (pharmaceutical drugs and salinity changes) can exert different threats than each stressor acting individually; for example, salinity can change the physical-chemical properties of the drugs and/or the sensitivity of the organisms to them. However, limited information is available on this subject, with variable results, and for this reason, this study aimed to evaluate the impacts of salinity changes (15, 25 and 35) on the effects of the antiepileptic carbamazepine (CBZ, 1 μg/L) and the antihistamine cetirizine (CTZ, 0.6 μg/L), when acting individually and combined (CBZ + CTZ), in the edible clam Ruditapes philippinarum. After 28 days of exposure, drugs concentrations, bioconcentration factors and biochemical parameters, related to clam's metabolic capacity and oxidative stress were evaluated. The results showed that clams under low salinity suffered more changes in metabolic, antioxidant and biotransformation activities, in comparison with the remaining salinities under study. However, limited impacts were observed when comparing drug effects at low salinity. Indeed, it seemed that CTZ and CBZ + CTZ, under high salinity (salinity 35) were the worst exposure conditions for the clams, since they caused higher levels of cellular damage. It stands out that salinity changes altered the impact of pharmaceutical drugs on marine bivalves.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-01T00:00:00Z
2022-02-01
2024-02-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/37737
url http://hdl.handle.net/10773/37737
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0048-9697
10.1016/j.scitotenv.2021.150369
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777303601616519168